|
Volumn 29, Issue 3, 1999, Pages 294-297
|
Do inhaled corticosteroids reduce serum IgE levels? The answer is maybe but how relevant is the question? Editorial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIASTHMATIC AGENT;
BECLOMETASONE DIPROPIONATE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
CORTICOSTEROID;
HYDROCORTISONE;
IMMUNOGLOBULIN E;
PLACEBO;
RECOMBINANT INTERLEUKIN 4;
SALBUTAMOL;
ALLERGIC ASTHMA;
ANIMAL MODEL;
ASTHMA;
ATOPY;
BRONCHUS HYPERREACTIVITY;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
DOUBLE BLIND PROCEDURE;
DRUG MECHANISM;
EDITORIAL;
HUMAN;
IMMUNOGLOBULIN BLOOD LEVEL;
INHALATIONAL DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
STEROID THERAPY;
TREATMENT OUTCOME;
ADMINISTRATION, INHALATION;
ADRENAL CORTEX HORMONES;
ASTHMA;
HUMANS;
IMMUNOGLOBULIN E;
|
EID: 0032967926
PISSN: 09547894
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2222.1999.00524.x Document Type: Editorial |
Times cited : (5)
|
References (37)
|